Bioasis Tech Stock Price, News & Analysis
Company Description
Bioasis Tech (OTC Link: BIOAF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $288.9K.
BIOAF stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of BIOAF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bioasis Tech (BIOAF) stock last traded at $0.0000. At a market capitalization of $288.9K, BIOAF is classified as a micro-cap stock with approximately 79.4M shares outstanding.
Latest News
Bioasis Tech has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include acquisition. View all BIOAF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BIOAF Company Profile & Sector Positioning
Bioasis Tech (BIOAF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BIOAF often look at related companies in the same sector, including Altamira Therapeutics Ltd (CYTOF), Respirerx Pharma (RSPI), Panbela Therapeutics Inc (PBLA), Chitogenx (CHNXF), and Viracta Therapeutics Inc (VIRX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BIOAF's relative position within its industry.